Coil treatment showdown: one side or both for brain bleed?

NCT ID NCT07715656

Recruiting now Disease control Sponsor: Lahey Clinic Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial tests whether blocking the blood supply to a chronic subdural hematoma (a slow brain bleed) on one side or both sides works better. Adults with a unilateral hematoma will receive either unilateral or bilateral coil embolization. The study measures changes in hematoma size and the need for additional surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: coil embolization of the middle meningeal artery
What this could lead to: If successful, this could establish a standard approach for treating chronic subdural hematomas with fewer repeat surgeries.
What could go wrong: This is a mid-sized trial comparing two techniques; results may not show a clear advantage, and risks like bleeding or stroke remain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC SUBDURAL HEMATOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hematoma, Subdural, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC SUBDURAL HEMATOMA

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Lahey Hospital & Medical Center
RECRUITING

Burlington, Massachusetts, 01803, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.